Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Oncoimmunology|October 30, 2013
Immunological consequences of selective BRAF inhibitors in malignant melanoma: Neutralization of myeloid-derived suppressor cellsBastian Schilling, Annette PaschenAmerican Journal of Clinical Dermatology|February 24, 2017
Next-Generation Sequencing to Guide Treatment of Advanced MelanomaKlaus G Griewank, Bastian SchillingDeutsche Medizinische Wochenschrift (1946)|November 30, 2020
[Endocrine side effects of cancer immunotherapy]Matthias Kroiß, Bastian Schilling, Timo DeutschbeinJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 25, 2026
Neoadjuvant therapy in skin cancer: current evidence and future perspectivesLea Daniello, Johannes Kleemann, Bastian SchillingAmerican Journal of Clinical Dermatology|March 4, 2020
Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?Patrick Schummer, Bastian Schilling, Anja GesierichOncology Letters|September 12, 2012
Adjuvant pegylated interferon α-2b therapy for melanomaBastian Schilling, Julia Vaubel, Dirk SchadendorfExpert Opinion on Biological Therapy|August 2, 2012
Induced and natural regulatory T cells in human cancerTheresa L Whiteside, Patrick Schuler, Bastian SchillingJournal of Leukocyte Biology|May 11, 2019
Chemoirradiated neutrophils and T cells differentially affect immune functions of APCsCindy Franklin, Kirsten Bruderek, Bastian Schilling, et al.Cancer Immunology Research|June 21, 2020
Identification of the Cryptic HLA-I ImmunopeptidomeFlorian Erhard, Lars Dölken, Bastian Schilling, et al.Journal of Cutaneous Pathology|May 22, 2021
Aberrant cytoplasmic connexin43 expression as a helpful marker in vascular neoplasmsVerena Gerlinde Frings, Matthias Goebeler, Bastian Schilling, et al.Pageof 17